SUN bioscience is enabling personalized medicine through its SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. Our flagship technology Gri3D® is solving the challenges of organoid culture: automation, robustness, scalability, and easy imaging. This will introduce a new era in drug development.
